A comprehensive understanding of growth control in normal mammalian cells requires that we know how gene regulatory circuits operate as a function of the cell cycle. The transcription factor, E2F, and pRB, a tumor suppressor known to restrain E2F activity, are among the best-studied regulators of cell cycle dependent gene expression. Pathways that involve pRB are known to be de-regulated in a majority of human cancers. Despite the fact that E2F and pRB have been linked genetically to growth control, the mechanisms by which these factors modulate endogenous gene expression and globally regulate cell cycle progression are not well understood. A complete description of their function requires that we understand not only physiological changes that occur at a given cell cycle regulated promoter but also the intricate biochemical mechanisms that switch a gene from the 'OFF' to 'ON' state in a reversible manner during the cell cycle. A detailed description can be achieved only by studying the regulation of E2F targets in a natural (chromatin) setting under conditions where cells are either stimulated to grow or are continuously cycling. Our hypothesis suggests that discrete mechanisms must exist that distinguish gene expression profiles during each stage of the cell cycle. Given the pivotal role of pRB in tumor suppression, an understanding of these mechanisms will provide crucial clues necessary for understanding the regulation of normal cell growth and the ways in which controls may go awry in human cancer. This Research Proposal takes advantage of multiple, complementary approaches to test this idea.
In Aim 1, a combination of genomics and biochemistry will be used to identify targets of E2F and pRB families and chromatin modifying enzymes in proliferating cells at each stage of the cell cycle to determine those factors that regulate genes in both active and inactive states. Using rapidly emerging bioinformatics and computational tools, approaches in Aim 2 will attempt to identify those patterns that link genes co-regulated by E2F, pRB, and chromatin modifying enzymes. Biochemical experiments in Aim 3 will test predictions about these patterns and will reveal those mechanisms that distinguish expression profiles of native E2F target genes at different stages of the cell cycle. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA077245-07
Application #
6781335
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Mietz, Judy
Project Start
1998-06-19
Project End
2009-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
7
Fiscal Year
2004
Total Cost
$308,680
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Cheng, Jemmie; Blum, Roy; Bowman, Christopher et al. (2014) A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers. Mol Cell 53:979-92
Bowman, Christopher John; Ayer, Donald E; Dynlacht, Brian David (2014) Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat Cell Biol 16:1202-14
Vethantham, Vasupradha; Yang, Yan; Bowman, Christopher et al. (2012) Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation. Mol Cell Biol 32:1044-55
Li, Yirong; Zhang, David Y; Ren, Qinghu et al. (2012) Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching. Mol Cell Biol 32:2454-66
Blum, Roy; Vethantham, Vasupradha; Bowman, Christopher et al. (2012) Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1. Genes Dev 26:2763-79
Asp, Patrik; Blum, Roy; Vethantham, Vasupradha et al. (2011) Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci U S A 108:E149-58
van Oevelen, Chris; Bowman, Christopher; Pellegrino, Jessica et al. (2010) The mammalian Sin3 proteins are required for muscle development and sarcomere specification. Mol Cell Biol 30:5686-97
van Oevelen, Chris; Wang, Jinhua; Asp, Patrik et al. (2008) A role for mammalian Sin3 in permanent gene silencing. Mol Cell 32:359-70
Lents, Nathan H; Wheeler, Leroy W; Baldassare, Joseph J et al. (2008) Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D. Cell Cycle 7:1580-6
Bar-Joseph, Ziv; Siegfried, Zahava; Brandeis, Michael et al. (2008) Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells. Proc Natl Acad Sci U S A 105:955-60

Showing the most recent 10 out of 21 publications